Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
William Camu, Philippe Lehert, Charles Pierrot‐Deseilligny, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 5
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
Emma L. Bishop, Aiten Ismailova, Sarah Dimeloe, et al.
JBMR Plus (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 274
Vitamin D and neurodegenerative diseases
Weixia Wang, Yijin Li, Xianfang Meng
Heliyon (2023) Vol. 9, Iss. 1, pp. e12877-e12877
Open Access | Times Cited: 53
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
Julia Feige, Tobias Moser, Lara Bieler, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 783-783
Open Access | Times Cited: 111
The role of vitamin D in autoimmune diseases: could sex make the difference?
Maria Luisa Dupuis, Maria Pagano, Marina Pierdominici, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 86
An Update on Vitamin D and Disease Activity in Multiple Sclerosis
Joost Smolders, Øivind Torkildsen, William Camu, et al.
CNS Drugs (2019) Vol. 33, Iss. 12, pp. 1187-1199
Open Access | Times Cited: 80
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history
Per Soelberg Sørensen, Finn Sellebjerg, Hans-Peter Hartung, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2637-2652
Open Access | Times Cited: 75
A Brief Review of the Effects of Vitamin D on Multiple Sclerosis
Andrei Miclea, Maud Bagnoud, Andrew Chan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 70
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications
Manon Galoppin, Saniya Kari, Sasha Soldati, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 46
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Stéphanie Andrade, Débora Nunes, Meghna Dabur, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 212-212
Open Access | Times Cited: 28
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Amarpreet Sangha, Michaela Quon, Gerald Pfeffer, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2978-2978
Open Access | Times Cited: 28
High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
Sandra D. Cassard, Kathryn C. Fitzgerald, Peiqing Qian, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101957-101957
Open Access | Times Cited: 26
Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders
Md Jamir Anwar, Sattam Khulaif Alenezi, Ahmad Alhowail
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114718-114718
Open Access | Times Cited: 23
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
Patrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 118, Iss. 1
Open Access | Times Cited: 60
Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
Giuseppe Murdaca, Mónica Greco, Matteo Borro, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 7, pp. 102845-102845
Closed Access | Times Cited: 52
Vitamins D2 and D3 Have Overlapping But Different Effects on the Human Immune System Revealed Through Analysis of the Blood Transcriptome
Louise R. Durrant, Giselda Bucca, Andrew Hesketh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Vitamin D in Neurological Diseases
Domenico Plantone, Guido Primiano, Carlo Manco, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 87-87
Open Access | Times Cited: 36
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
Sara E. Gombash, Priscilla W. Lee, Elizabeth Sawdai, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 35
Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis
Marijne Vandebergh, Bénédicte Dubois, An Goris
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 31
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches
Eleni S. Vasileiou, Kathryn C. Fitzgerald
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 9, pp. 481-496
Closed Access | Times Cited: 19
Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis
Danyal Imani, Bahman Razi, Morteza Motallebnezhad, et al.
BMC Neurology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 51
Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies
Marijne Vandebergh, Nicolas Degryse, Bénédicte Dubois, et al.
Journal of Neurology (2022) Vol. 269, Iss. 8, pp. 4565-4574
Closed Access | Times Cited: 25
Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials
João Vitor Mahler, Marina Solti, Samira Luísa Apóstolos‐Pereira, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 82, pp. 105433-105433
Closed Access | Times Cited: 5
Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis
Gina Chang, Prince Sebastian, Akash Virupakshaiah, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Closed Access
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis
Éric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
JAMA (2025)
Closed Access
Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome
Manon Rival, Manon Galoppin, Éric Thouvenot
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top